indivior
Top Ten most popular articles on Pharmafile.com this week!
April 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, BMS, Eisai, Gilead, MSD, Pfizer, ViiV, indivior
This week was an excellent week for recommendations and approvals after Eisai, MSD, Pfizer, BMS and ViiV scored wins. Meanwhile …
Indivior shares fall by 70% after allegations of fraud
April 10, 2019Research and Development Virginia, indivior, opioid crisis, opioids, suboxone
Shares in London-listed Indivior plummeted this morning after US Federal prosecutors said the British drugmaker had deceived doctors as to …
Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film
March 12, 2019Manufacturing and Production Dr Reddy's, Suboxone Film, court, indivior, opioid addiction
Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales …
Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market
February 21, 2019Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior
Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …
Indivior rocked by loss of patent case
March 23, 2018Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical
Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
Indivior’s opioid addiction treatment recommended by FDA advisory panel
November 1, 2017Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
Indivior reaches settlement with Mylan over patent dispute
September 25, 2017Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone
Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …
Reckitt finalises pharmaceutical demerger plans
November 19, 2014Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone
Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …
